- Home
- GEVO vs BNTC Comparison
GEVO vs BNTC Comparison
Compare GEVO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- BNTC
- Stock Information
- Founded
- GEVO 2005
- BNTC 1995
- Country
- GEVO United States
- BNTC United States
- Employees
- GEVO N/A
- BNTC N/A
- Industry
- GEVO Major Chemicals
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- BNTC Health Care
- Exchange
- GEVO Nasdaq
- BNTC Nasdaq
- Market Cap
- GEVO 246.8M
- BNTC 366.6M
- IPO Year
- GEVO 2011
- BNTC N/A
- Fundamental
- Price
- GEVO $1.49
- BNTC $12.89
- Analyst Decision
- GEVO Buy
- BNTC Strong Buy
- Analyst Count
- GEVO 2
- BNTC 6
- Target Price
- GEVO $7.58
- BNTC $23.83
- AVG Volume (30 Days)
- GEVO 5.3M
- BNTC 234.8K
- Earning Date
- GEVO 08-07-2025
- BNTC 05-14-2025
- Dividend Yield
- GEVO N/A
- BNTC N/A
- EPS Growth
- GEVO N/A
- BNTC N/A
- EPS
- GEVO N/A
- BNTC N/A
- Revenue
- GEVO $42,034,000.00
- BNTC N/A
- Revenue This Year
- GEVO $1,022.79
- BNTC N/A
- Revenue Next Year
- GEVO $12.26
- BNTC N/A
- P/E Ratio
- GEVO N/A
- BNTC N/A
- Revenue Growth
- GEVO 145.38
- BNTC N/A
- 52 Week Low
- GEVO $0.48
- BNTC $7.05
- 52 Week High
- GEVO $3.39
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- GEVO 58.73
- BNTC 50.13
- Support Level
- GEVO $1.17
- BNTC $12.57
- Resistance Level
- GEVO $1.50
- BNTC $13.88
- Average True Range (ATR)
- GEVO 0.10
- BNTC 1.18
- MACD
- GEVO 0.02
- BNTC 0.02
- Stochastic Oscillator
- GEVO 72.73
- BNTC 62.63
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.